Abstract
The number of high-risk patients undergoing surgery is growing. To maintain adequate hemodynamic conditions as well as oxygen delivery to the vital organs (DO2) among this patient population, a rapid assessment of cardiac function is essential. In this context, hemodynamic focused echocardiography offers an excellent opportunity to examine the signs of cardiac filling impairment, preload, myocardial contractility, and the function of the heart valves. In this chapter, a practical six-step approach towards a perioperative echocardiographic-based hemodynamic optimization is presented. The summary of all echocardiographic findings and their integration in the clinical context along with the patients’ medical background allows a differentiated assessment of the patient’s cardiovascular function and can thus help guide a (patho)physiological-orientated and individualized hemodynamic therapy.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
1 Introduction
Adequate oxygen delivery (DO2) is critical for the maintenance of physiological homeostasis and organ function and is significantly dependent upon cardiac stroke volume (SV). The determinants of SV are pre- and afterload, intrinsic contractility, heart rate/rhythm, and valve function. A critically reduced DO2 due to a compromised SV in the perioperative setting can worsen outcome especially in high-risk patients with preexisting cardiovascular risk factors [1,2,3].
In this context, hemodynamic focused echocardiography provides a real-time pathophysiologically oriented approach, which allows guiding cardiovascular therapy [4,5,6,7,8,9,10,11,12]. It has been shown that the use of an echocardiography-based hemodynamic optimization protocol improved outcomes among septic patients in an the intensive care unit (ICU) setting [13,14,15]. In hemodynamically unstable patients unresponsive to initial treatment, there exists a class I indication for performing a timely echocardiographic examination in order to accurately assess and implement interventions aimed at maintaining hemodynamic stability [12, 16,17,18,19]. In order to adequately interpret and evaluate echocardiographic findings, however, a standardized curricular training and continuously available supervision is inevitable [20, 21]. In addition, “focused examiners” have the responsibility to seek expert help whenever needed.
In this chapter, a practical six-step approach toward a perioperative echocardiographic-based hemodynamic optimization is presented. It should be noted that the proposed algorithm may be used “as needed” in the case of hemodynamic instability or “as a predefined monitoring tool” within a goal-directed treatment strategy with monitoring intervals appropriately addressing the patient’s hemodynamic risk. It may also be beneficial to be able to compare perioperative echocardiographic findings with a preoperative baseline exam. Nevertheless, it is of importance that echocardiographic findings must always be interpreted in the context of the clinical situation along with the patients’ medical background. For instance, fluid substitution will be indicated in a trauma patient with low blood pressure, overall small heart chambers and a small inferior vena cava on echocardiography.
2 Imaging Views
The following views should be used within a hemodynamic focused transthoracic (TTE) or transesophageal (TEE) echocardiography:
2.1 Transthoracic Echocardiography: Parasternal Long and Short Axis, Apical or Subcostal Four-Chamber View with Subcostal View of the Inferior Vena Cava
In order to obtain a parasternal long-axis (PLAX) view (Fig. 10.1), the cardiac ultrasound probe needs to be placed on the thorax in the left parasternal position, with the marker pointing toward the right shoulder. An optimal view should be gained via carefully moving the probe between the intercostal spaces (ICS), starting from the second ICS to the fifth ICS. Once the most optimal view has been obtained, the following structures should be apparent in the PLAX: the right ventricular outflow tract, the interventricular septum with the upper aortic wall, the aortic valve, the left atrium, the mitral valve, the left ventricle without the cardiac apex, and the posterior wall of the left ventricle. With the PLAX view, a global assessment of major cardiac structures, as well as volume status, myocardial morphology, and valve status can be assessed. Next, the parasternal short-axis (PSAX) view (Fig. 10.2) can be obtained by simply rotating the probe clockwise 90°, so that the marker on the probe is in the direction of the left shoulder.
Once the optimal view has been obtained, the following structures should become apparent: the cross-shaped left ventricle with the anterior, inferior, septal, and lateral wall segments. Adjacent to this is the crescent-shaped right ventricle. The cardiac apex, the cross-shaped aortic, and mitral valves, as well as the anterolateral and posteromedial papillary muscles, can be obtained via angulating the probe from cranial to caudal. Additionally, the pulmonary valve, the main pulmonary artery trunk, its associated branches, and the right and left pulmonary arteries can be visualized at the level of the aortic valve, normally seen on the right-hand side of the monitor. On the opposite side of the monitor, additional cardiac structures such as the aortic valve, right atrium, tricuspid valve, and right ventricle can be visualized.
The next view which should be acquired is the apical four-chamber (4C) view (Fig. 10.3), which is best visualized by probe placement in the fifth ICS, between the medioclavicular and posterior axillary line, while the probe marker is pointing to the direction of the left shoulder.
Similarly to the PLAX view, the 4C view requires the movement of the probe between the ICS in order to obtain the best examination window.
Upon obtainment of the 4C view, both the atria and ventricles, along with the tricuspid and mitral valves become apparent. In the middle of the sonographic window, the interventricular septum should be present. In order to prevent the underestimation of left ventricular, as well as the overestimation of the right ventricular dimensions, the lowest ICS 4C view should be used. This prevents the so-called “foreshortening.”
Additionally, the 4C view allows for the visualization of the left ventricular wall, which includes the inferior septal wall, and the anterior-lateral wall on the opposite side. Furthermore, a five-chamber (5C) view, which includes the left ventricular outflow tract and aortic valve, can be observed via probe angulation cranially. To round out the TTE, a final view should be obtained, aptly termed the subcostal four-chamber (S4C) view (Fig. 10.4). This is performed by placing the probe inferior to the xiphoid process, with the marker pointing to the patients’ left side.
In this view, a four-chamber view along with the tricuspid and mitral valves is seen. The last structure which needs to be obtained for a comprehensive hemodynamic is the inferior vena cava (IVC) (Fig. 10.5), which can be visualized by rotating the marker toward the head of the patient. This step-by-step method rounds out the TTE assessment.
Practical Advice
In the PLAX view, the highest intercostal view that yields a sufficient image should be used, whereas in the 4C view, the lowest intercostal space as lateral as possible should be used to prevent foreshortening.
2.2 Transesophageal Echocardiography: Midesophageal Four-Chamber view, Midesophageal View of the Superior Vena Cava, Transgastric Short Axis View [22]
The first step is passing the probe through the upper esophageal sphincter until the first image of the left atrium is obtained. Usually, this occurs upon a 30-cm depth from the dental arch. Upon obtaining the view of the left atrium, the probe is described as being in the transesophageal position. From this position, the midesophageal four-сhamber (ME4C) view (Fig. 10.6) can be obtained. By rotating the image, the left ventricular axis and the apex should become apparent in the sectional image. Similar to the 4C view of the TTE, the foreshortening of the left ventricle should be kept in mind. The annulus diameter of both atrioventricular valves should be acquired, while attempting to maximize the views of these valves in order to assess valve function and morphology. This can be achieved by retroflecting the probe and rotating the probe by 0–20°.
The next structures to be visualized are the right ventricle and the tricuspid valve, which should be directly in the center of the monitor. This is done by tilting the probe to the right. In order to obtain the optimal views of the great caval veins entering into the right atrium, interatrial septum, and the fossa ovalis area, the probe should be rotated 100°, thereby acquiring the bicaval view (Fig. 10.7) and the midesophageal view of the SVC.
By increasing the depth of the probe approximately 40–45 cm from the dental arch, with the probe in the “0” position of flexion and rotation without applying force, the image is momentarily lost. Upon this loss of image, the probe should be placed in the anteflexion position and retracted until the cross-sections of the left and right ventricles are observable. The probe should then be rotated until the cross-sections of both papillary muscles are obtained and the entire symmetric left ventricle is acquired. Thereby the transgastric short-axis (TGSAX) view (Fig. 10.8) is obtained. This is an excellent position to assess the left ventricle at the midpapillary level as well as wall motion of all coronary regions. Also, this view can be reliably utilized to assess cardiac volume status and contractility.
Practical Advice
If the insertion of the TEE probe is difficult, the performance of an Esmarch (jaw thrust) maneuver as well as the usage of a laryngoscope can be helpful.
3 Hemodynamic Assessment
The next section details a step-by-step algorithmic approach for rapid hemodynamic assessment in order to optimize SV function in the high-risk surgical patient. All steps encompass the TTE and TEE approach.
The additional use of (color) Doppler modalities may allow for semiqualitative evaluation of the heart valves [23]. Though TTE is noninvasive and may be the method of choice, TEE may offer better image quality, particularly in patients with morbid obesity or on mechanical ventilation [24]. Nevertheless, image acquisition will be impossible in some patients at all as well as in most patients in prone position.
4 Step 1: Cardiac Filling Impairment
The first step is to rule out cardiac filling impairment due to pericardial effusion or tamponade requiring immediate evacuation. Not only in the cardiac surgery setting but also due to trauma or due to chronic disease, a relevant accumulation of fluid in the pericardium can occur [25,26,27,28]. Echocardiographic signs of hemodynamically relevant pericardial effusions may include the existence of pericardial effusion with consecutive hypovolemia of all heart chambers, collapse of the right cardiac chambers, and/or dilatation of IVC. When using a TTE, the S4C view should be used, while for TEE, the ME4C should be used initially.
5 Step 2: Volume Status
The second step is to estimate the volume status of the patient, as both hypo- and hypervolemia can reduce SV and thus DO2. The four-chamber (4C) views and the short-axis (SAX) views at the level of the papillary muscles are suitable for obtaining a quick overview.
Although resting diameters for cardiac chambers are gender and body surface area specific [29], the size of the left ventricle (LV) and the right ventricle (RV) should be measured. An end-diastolic left ventricular diameter (LVEDD) of 35–55 mm may reflect normal LV, and a basal RV diameter of ≤41 mm may reflect normal RV size. Qualitatively, hemodynamic-relevant hypovolemia may provoke a “kissing papillary muscle” sign: the opposite myocardial walls of the corresponding ventricle come in contact with one another during systole. Nevertheless, a preoperative dilated LV (e.g., LVEDD 65 mm) due to a reduced global systolic function may be interpreted as “hypovolemic” if the LVEDD is within normal range (e.g., LVEDD 50 mm).
Practical Advice
A pronounced concentric hypertrophy as evidenced by a myocardial wall thickness of >14 mm (i.e., due to severe aortic stenosis) must be excluded prior to the diagnosis of hypovolemia [30]!
The assessment of the interatrial septum (IAS) in the four-chamber (4C, ME4C) views can be used for qualitative estimation of atrial filling pressures. A hypermobile IAS is commonly observed during global hypovolemia. A sole increase in left atrial filling pressure will shift the IAS permanently convex to the right, whereas increased right atrial filling pressure shifts the IAS permanently convex to the left atrium in combination with the left cardiac hypovolemia [31]. Global hypervolemia may be identified with all heart chambers appearing “overfilled” or “stretched” and a in the middle-fixated IAS [32, 33].
Volume responsiveness can be estimated by interrogating the IVC via TTE or the SVC via TEE. The IVC diameter may be used to estimate the right atrial filling pressure [34]. In awake and spontaneously breathing patients, the normal diameter for the IVC is <21 mm [35]. During mechanical inspiration, venous return is reduced due to the increased intrathoracic pressure and the IVC distends (“IVC-distensibility index, DI”) [36]. Thus, the more pronounced intravascular hypovolemia is present, the greater the IVC will distend [37]. An IVC-DI of >18% in controlled ventilated septic patients may indicate a positive volume response resulting in an increased cardiac output (CO) after fluid resuscitation [38,39,40,41,42]. In patients with preserved spontaneous respiration, the patient is asked to inspire deeply once and expire passively afterward, while the variation in IVC diameter is recorded [43]. An IVC diameter variability of ≥48% represents a positive volume response. The same is also possible with TEE using the SVC collapse index (SVC-CI) [44]. In contrast, the SVC will be compressed during mechanical inspiration due to its intrathoracic position: SVC collapse index (SVC-CI) [44]. A SVC-CI of >36% measured with TEE indicates a positive volume response. Nonetheless, like many other methods, these easy-to-determine quantitative variables are subject to individual cut-off variations (e.g., IVC-DI “gray zone” 8–30%) [42, 45,46,47,48]. Therefore, in extension to quantitative determinations, the approach shown in Table 10.1 may be helpful in deciphering the measurements taken from the IVC/SVC [49,50,51].
However, from a clinical point of view, one has to differentiate between (a) “relative” hypovolemia (i.e., all heart chambers appeared to be “normally” filled; however, additional fluid substitution may cause an increase in SV—“volume responsiveness”), (b) “global” hypovolemia (i.e., all heart chambers are reduced in size due to a significant reduction in the total circulating blood volume—additional fluid substitution will lead to an increase in SV), and (c) “partial” hypovolemia (i.e., LV hypovolemia in the case of RV failure—fluid substitution will mostly not be effective in increasing left ventricular SV because of the incapability of the RV).
6 Step 3: Right Ventricle Function
A restricted RV function is associated with increased perioperative mortality [52,53,54]. Additionally, sufficient LV function depends on sufficient preload provided by the RV [55]. The RV thus may be assessed prior to LV assessment [56].
This is achieved by measuring RV diameter (Step 2) as well as the volume/diameter relation between the right and left ventricles, the “RV/LV index” (≤0.6). A RV/LV index of ≥1.0 indicates a severe RV dilatation [57]. Hypertrophy of the free right ventricular wall (>5 mm) may indicate a chronic disease process [58]. The thickness of the right ventricular wall is best measured from the subcostal at the level of the anterior tricuspid valve tip or alternatively in the PLAX [34].
RV contractility is assessed in the four-chamber views. With a normal RV function, the free RV wall should move inward [34]. The systolic movement of the lateral tricuspid valve annulus toward the apex (tricuspid annular plane systolic excursion, TAPSE) (Fig. 10.9) can be used as a quantitative measurement. A TAPSE of ≥17 mm indicates a normal systolic RV function [34]. Hemodynamically relevant RV dysfunction may be suspected if the RV appears dilated with impaired systolic function. In addition, RV overloading can displace the interventricular septum toward the LV (“paradoxical septum shift”) (D-sign) (Fig. 10.10), thereby further restricting cardiac function.
Practical Advice
The acuity of a right ventricular dysfunction can be differentiated based on the diameter of the right ventricular wall. A hypertrophy of the free right ventricular wall (>5 mm) indicates a chronic disease process, whereas a normal right ventricular wall and signs of right ventricular dysfunction propose an acute pathology.
7 Step 4: Left Ventricle Function
LV should be assessed in an analogous manner to the RV (see also Steps 2 and 3). The left ventricular ejection fraction (LVEF) is determined to quantify global systolic function. For normal clinical concerns, however, a qualitative assessment of the LVEF (“eyeballing”) may be sufficient [59]. PSAX or TGSAX as well as four-chamber (4C or ME4C) views allow for a quick orientation [60].
Hemodynamic-relevant systolic LV dysfunction may be excluded if the LV appears nondilated with normal systolic function (LVEF >50%). However, isolated diastolic LV dysfunction (heart failure with preserved ejection fraction, HFpEF) may be present [61]. If diastolic dysfunction is suspected, an expert consultation should be made in order to guide further diagnostics and therapy [62]. However, a hypertrophied LV with normal systolic function in conjunction with a pronounced dilation of the left atrium (LA) may be related to HFpEF in a breathless patient with/without signs of pulmonary edema [63].
Finally, regional wall motion abnormalities—hypokinesia, akinesia, or dyskinesia [64]—may hint at specific cause such as myocardial infarction or takotsubo syndrome, which require a specific diagnostic testing (e.g., electrocardiogram, cardiac enzymes, coronary angiography) and treatment.
Practical Advice
If the LV appears nondilated with normal systolic function, hemodynamic-relevant systolic LV dysfunction can be excluded. However, if the patient shows clinical signs of heart failure and echocardiography reveals a hypertrophied LV and a pronounced dilation of the LA, HFpEF should be considered.
8 Step 5: Valve Function
The visual and thus qualitative evaluation of valves in the hemodynamic focused examination is used to assess valve opening and closure as well as to recognize morphological abnormalities. Thin leaflets with a normal opening/closing and without turbulent flow in the color Doppler determined in ≥2 cross-sectional views may exclude hemodynamic-relevant valve dysfunction. Hemodynamic-relevant stenosis may be suspected in the case of a thickened or calcified valve with a restricted opening resulting in antegrade flow accelerations/turbulences in the color Doppler. On the other hand, hemodynamic-relevant regurgitation might be suspected if a visible coaptation defect and/or an exaggerated leaflet motion during valve closing in conjunction with a wide, turbulent, backward color jet (“vena contracta”) (Fig. 10.11) is observed [23]. In suspicion of a hemodynamically relevant valve abnormality, a comprehensive evaluation should be performed immediately by a certified examiner [65,66,67].
Practical Advice
Thin leaflets with normal opening and closing and without turbulent color flow exclude hemodynamic-relevant valve dysfunction.
9 Step 6: Cardiac Output Estimation
Transthoracic and transesophageal echocardiography are capable of estimating cardiac output, although discontinuously, using continuous-wave (cw) Doppler across the left ventricular outflow tract (LVOT)/aortic valve (AV) measuring the velocity time integral (VTI) [68]. A VTI of 18–22 cm indicates a normal stroke volume, whereas a VTI of <18 cm suspects decreased stroke volume and >22 cm an increased one [69]. Prior to this, a relevant aortic stenosis must be excluded. However, echocardiography may not be interchangeable with other cardiac output monitoring [70]. Thus, a continuous hemodynamic monitoring should be implemented in hemodynamic unstable patients to assess the therapeutic success after initial echocardiographic evaluation [71, 72].
Practical Advice
A VTI of 18–22 cm indicates normal, a VTI of <18 cm decreased, and >22 cm increased stroke volume.
10 Conclusion
Hemodynamic focused echocardiography as a rapid bedside diagnostic method can examine signs of filling impairment, volume status and volume responsiveness, right and left ventricular function, and heart valve function as well as estimate cardiac output. Using a stepwise approach, high-risk patients within the perioperative setting can be assessed in the case of hemodynamic instability to rapidly pinpoint pathophysiological causes. The summary of all echocardiographic findings, including clinical symptoms and patient history, allows a differentiated assessment of the patient’s cardiovascular function and can thus help to guide a (patho)physiologically orientated and individualized hemodynamic therapy in order to optimize and maintain stroke volume.
Keynotes
-
Hemodynamic focused echocardiography allows to examine the signs of cardiac filling impairment, cardiac preload, myocardial contractility, and cardiac heart valve function.
-
Echocardiographic signs of filling impairment are pericardial effusion with hypovolemia of all heart chambers, collapse of right cardiac chambers, and/or dilatation of the inferior vena cava.
-
Volume status/responsiveness can be assessed by examining a potential kissing papillary muscle sign and the positioning and movement of the interatrial septum as well as the diameter and respiratory variation of the superior and inferior vena cava.
-
The right ventricle is assessed by examining the volume/diameter relation between the right and left ventricles, the diameter of the right ventricular wall, the movement of the right ventricular free wall, and the lateral tricuspid valve annulus toward the apex as well as the position and movement of the interventricular septum.
-
A qualitative assessment of the left ventricular ejection fraction with eyeballing may be equivalent to a quantitative one for normal clinical concerns in the context of a hemodynamically focused examination.
-
Thin leaflets with a normal opening/closing and without turbulent flow in color Doppler exclude hemodynamically relevant valve dysfunction.
-
A velocity time integral, measured with continuous-wave Doppler across the left ventricular outflow tract/aortic valve, of 18–22 cm indicates normal, whereas a VTI of <18 cm a decreased and >22 cm an increased stroke volume. Prior to this, aortic stenosis must be excluded.
Abbreviations
- 4C:
-
Four-chamber view
- AS:
-
Aortic stenosis
- AV:
-
Aortic valve
- CO:
-
Cardiac output
- DO2:
-
Oxygen delivery
- FAST:
-
Focused Assessment with Sonography in Trauma
- HFpEF:
-
Heart failure with preserved ejection fraction
- IAS:
-
Interatrial septum
- ICU:
-
Intensive care unit
- IVC:
-
Inferior vena cava
- LA:
-
Left atrium
- LV:
-
Left ventricle
- LVEDD:
-
End-diastolic left ventricular diameter
- LVEF:
-
Left ventricular ejection fraction
- LVOT:
-
Left ventricular outflow tract
- ME:
-
Midesophageal
- PLAX:
-
Parasternal long axis
- PPV:
-
Pulse pressure variation
- PSAX:
-
Parasternal short axis
- RV:
-
Right ventricle
- S4C:
-
Subcostal four-chamber view
- SAX:
-
Short axis
- SIVC:
-
Subcostal view of the inferior vena cava
- SIVC-DI:
-
SIVC-distensibility index
- SV:
-
Stroke volume
- SVC:
-
Superior vena cava
- SVC-CI:
-
SVC collapse index
- TAPSE:
-
Tricuspid annular plane systolic excursion
- TEE:
-
Transesophageal echocardiography
- TGSAX:
-
Transgastric short axis
- TTE:
-
Transthoracic echocardiography
- VTI:
-
Velocity time integral
References
Lieberman JA, Weiskopf RB, Kelley SD, Feiner J, Noorani M, Leung J, Toy P, Viele M. Critical oxygen delivery in conscious humans is less than 7.3 ml O2 x kg(−1) x min(−1). Anesthesiology. 2000;92(2):407–13.
Shoemaker WC, Appel PL, Kram HB. Hemodynamic and oxygen transport responses in survivors and nonsurvivors of high-risk surgery. Crit Care Med. 1993;21(7):977–90.
Hammill BG, Curtis LH, Bennett-Guerrero E, O’Connor CM, Jollis JG, Schulman KA, Hernandez AF. Impact of heart failure on patients undergoing major noncardiac surgery. Anesthesiology. 2008;108(4):559–67.
Cholley BP, Vieillard-Baron A, Mebazaa A. Echocardiography in the ICU: time for widespread use! Intensive Care Med. 2006;32(1):9–10. https://doi.org/10.1007/s00134-005-2833-8.
Balzer F, Trauzeddel RF, Ertmer M, Erb J, Heringlake M, Groesdonk HV, Goepfert M, Reuter DA, Sander M, Treskatsch S. Utilisation of echocardiography in intensive care units: results of an online survey in Germany. Minerva Anestesiol. 2019;85(3):263–70.
Price S, Platz E, Cullen L, Tavazzi G, Christ M, Cowie MR, Maisel AS, Masip J, Miro O, McMurray JJ, Peacock WF, Martin-Sanchez FJ, Di Somma S, Bueno H, Zeymer U, Mueller C. Expert consensus document: echocardiography and lung ultrasonography for the assessment and management of acute heart failure. Nat Rev Cardiol. 2017;14(7):427–40. https://doi.org/10.1038/nrcardio.2017.56.
Bainbridge D, McConnell B, Royse C. A review of diagnostic accuracy and clinical impact from the focused use of perioperative ultrasound. Can J Anesth. 2018;65(4):371–80. https://doi.org/10.1007/s12630-018-1067-5.
Jensen MB, Sloth E, Larsen KM, Schmidt MB. Transthoracic echocardiography for cardiopulmonary monitoring in intensive care. Eur J Anaesthesiol. 2004;21(9):700–7.
Benjamin E, Griffin K, Leibowitz AB, Manasia A, Oropello JM, Geffroy V, DelGiudice R, Hufanda J, Rosen S, Goldman M. Goal-directed transesophageal echocardiography performed by intensivists to assess left ventricular function: comparison with pulmonary artery catheterization. J Cardiothorac Vasc Anesth. 1998;12(1):10–5.
Manasia AR, Nagaraj HM, Kodali RB, Croft LB, Oropello JM, Kohli-Seth R, Leibowitz AB, DelGiudice R, Hufanda JF, Benjamin E, Goldman ME. Feasibility and potential clinical utility of goal-directed transthoracic echocardiography performed by noncardiologist intensivists using a small hand-carried device (SonoHeart) in critically ill patients. J Cardiothorac Vasc Anesth. 2005;19(2):155–9. https://doi.org/10.1053/j.jvca.2005.01.023.
Reeves ST, Finley AC, Skubas NJ, Swaminathan M, Whitley WS, Glas KE, Hahn RT, Shanewise JS, Adams MS, Shernan SK, Council on Perioperative Echocardiography of the American Society of E, Society of Cardiovascular A. Basic perioperative transesophageal echocardiography examination: a consensus statement of the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. J Am Soc Echocardiogr. 2013;26(5):443–56. https://doi.org/10.1016/j.echo.2013.02.015.
Kanji HD, McCallum J, Sirounis D, MacRedmond R, Moss R, Boyd JH. Limited echocardiography-guided therapy in subacute shock is associated with change in management and improved outcomes. J Crit Care. 2014;29(5):700–5. https://doi.org/10.1016/j.jcrc.2014.04.008.
Feng M, McSparron JI, Kien DT, Stone DJ, Roberts DH, Schwartzstein RM, Vieillard-Baron A, Celi LA. Transthoracic echocardiography and mortality in sepsis: analysis of the MIMIC-III database. Intensive Care Med. 2018;44(6):884–92. https://doi.org/10.1007/s00134-018-5208-7.
Cioccari L, Zante B, Bloch A, Berger D, Limacher A, Jakob SM, Takala J, Merz TM. Effects of hemodynamic monitoring using a single-use transesophageal echocardiography probe in critically ill patients - study protocol for a randomized controlled trial. Trials. 2018;19(1):362. https://doi.org/10.1186/s13063-018-2714-4.
Bouferrache K, Amiel JB, Chimot L, Caille V, Charron C, Vignon P, Vieillard-Baron A. Initial resuscitation guided by the surviving Sepsis campaign recommendations and early echocardiographic assessment of hemodynamics in intensive care unit septic patients: a pilot study. Crit Care Med. 2012;40(10):2821–7. https://doi.org/10.1097/CCM.0b013e31825bc565.
Cheitlin MD, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davis JL, Douglas PS, Faxon DP, Gillam LD, Kimball TR, Kussmaul WG, Pearlman AS, Philbrick JT, Rakowski H, Thys DM, Antman EM, Smith SC Jr, Alpert JS, Gregoratos G, Anderson JL, Hiratzka LF, Faxon DP, Hunt SA, Fuster V, Jacobs AK, Gibbons RJ, Russell RO. ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE committee to update the 1997 guidelines for the clinical application of echocardiography). J Am Soc Echocardiogr. 2003;16(10):1091–110. https://doi.org/10.1016/S0894-7317(03)00685-0.
Manning WJPD. Clinical cardiovascular magnetic resonance imaging techniques. In: Cardiovascular magnetic resonance, vol. 2. Philadelphia: Elsevier; 2010. p. 19–36.
Cecconi M, De Backer D, Antonelli M, Beale R, Bakker J, Hofer C, Jaeschke R, Mebazaa A, Pinsky MR, Teboul JL, Vincent JL, Rhodes A. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med. 2014;40(12):1795–815. https://doi.org/10.1007/s00134-014-3525-z.
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonzáles-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, Members ATF. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129–200. https://doi.org/10.1093/eurheartj/ehw128.
Greim CA, Weber S, Göpfert M, Groesdonk H, Treskatsch S, Wolf B, Zahn P, Müller M, Zenz S, Rauch H, Molitoris U, Ender J. Perioperative fokussierte Echokardiographie in der Anästhesiologie und Intensivmedizin. Anästh Intensivmed. 2017;58:616–48.
Spencer KT, Kimura BJ, Korcarz CE, Pellikka PA, Rahko PS, Siegel RJ. Focused cardiac ultrasound: recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr. 2013;26(6):567–81. https://doi.org/10.1016/j.echo.2013.04.001.
Treskatsch S, Balzer F, Knebel F, Habicher M, Braun JP, Kastrup M, Grubitzsch H, Wernecke KD, Spies C, Sander M. Feasibility and influence of hTEE monitoring on postoperative management in cardiac surgery patients. Int J Cardiovasc Imaging. 2015;31(7):1327–35. https://doi.org/10.1007/s10554-015-0689-8.
Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, Hahn RT, Han Y, Hung J, Lang RM, Little SH, Shah DJ, Shernan S, Thavendiranathan P, Thomas JD, Weissman NJ. Recommendations for noninvasive evaluation of native Valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2017;30(4):303–71. https://doi.org/10.1016/j.echo.2017.01.007.
Jorgensen MR, Juhl-Olsen P, Frederiksen CA, Sloth E. Transthoracic echocardiography in the perioperative setting. Curr Opin Anaesthesiol. 2016;29(1):46–54. https://doi.org/10.1097/ACO.0000000000000271.
Kirkpatrick AW, Sirois M, Laupland KB, Liu D, Rowan K, Ball CG, Hameed SM, Brown R, Simons R, Dulchavsky SA, Hamiilton DR, Nicolaou S. Hand-held thoracic sonography for detecting post-traumatic pneumothoraces: the extended focused assessment with sonography for trauma (EFAST). J Trauma. 2004;57(2):288–95. https://doi.org/10.1097/01.TA.0000133565.88871.E4.
Helling TS, Duke P, Beggs CW, Crouse LJ. A prospective evaluation of 68 patients suffering blunt chest trauma for evidence of cardiac injury. J Trauma. 1989;29(7):961–5.
Helling TS, Wilson J, Augustosky K. The utility of focused abdominal ultrasound in blunt abdominal trauma: a reappraisal. Am J Surg. 2007;194(6):728–32. https://doi.org/10.1016/j.amjsurg.2007.08.012.
Medicine AIoUi, Physicians ACoE. AIUM practice guideline for the performance of the focused assessment with sonography for trauma (FAST) examination. J Ultrasound Med. 2014;33(11):2047–56.
Kou S, Caballero L, Dulgheru R, Voilliot D, De Sousa C, Kacharava G, Athanassopoulos GD, Barone D, Baroni M, Cardim N, Gomez De Diego JJ, Hagendorff A, Henri C, Hristova K, Lopez T, Magne J, De La Morena G, Popescu BA, Penicka M, Ozyigit T, Rodrigo Carbonero JD, Salustri A, Van De Veire N, Von Bardeleben RS, Vinereanu D, Voigt JU, Zamorano JL, Donal E, Lang RM, Badano LP, Lancellotti P. Echocardiographic reference ranges for normal cardiac chamber size: results from the NORRE study. Eur Heart J Cardiovasc Imaging. 2014;15(6):680–90. https://doi.org/10.1093/ehjci/jet284.
Gaasch WH, Zile MR. Left ventricular structural remodeling in health and disease: with special emphasis on volume, mass, and geometry. J Am Coll Cardiol. 2011;58(17):1733–40. https://doi.org/10.1016/j.jacc.2011.07.022.
Kusumoto FM, Muhiudeen IA, Kuecherer HF, Cahalan MK, Schiller NB. Response of the interatrial septum to transatrial pressure gradients and its potential for predicting pulmonary capillary wedge pressure: an intraoperative study using transesophageal echocardiography in patients during mechanical ventilation. J Am Coll Cardiol. 1993;21(3):721–8.
Royse CF, Royse AG, Soeding PF, Blake DW. Shape and movement of the interatrial septum predicts change in pulmonary capillary wedge pressure. Ann Thorac Cardiovasc Surg. 2001;7(2):79–83.
Johansson MC, Guron CW. Leftward bulging of atrial septum is provoked by nitroglycerin and by sustained valsalva strain. J Am Soc Echocardiogr. 2014;27(10):1120–7.
Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK, Schiller NB. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010;23(7):685–713. https://doi.org/10.1016/j.echo.2010.05.010.
Ciozda W, Kedan I, Kehl DW, Zimmer R, Khandwalla R, Kimchi A. The efficacy of sonographic measurement of inferior vena cava diameter as an estimate of central venous pressure. Cardiovasc Ultrasound. 2016;14(1):33. https://doi.org/10.1186/s12947-016-0076-1.
Barbier C, Loubières Y, Schmit C, Hayon J, Ricôme J-L, Jardin F, Vieillard-Baron A. Respiratory changes in inferior vena cava diameter are helpful in predicting fluid responsiveness in ventilated septic patients. Intensive Care Med. 2004;30(9):1740–6. https://doi.org/10.1007/s00134-004-2259-8.
Das SK, Choupoo NS, Pradhan D, Saikia P, Monnet X. Diagnostic accuracy of inferior vena caval respiratory variation in detecting fluid unresponsiveness: a systematic review and meta-analysis. Eur J Anaesthesiol. 2018;35(11):831–9. https://doi.org/10.1097/EJA.0000000000000841.
Long E, Oakley E, Duke T, Babl FE, (PREDICT) PRiEDIC. Does respiratory variation in inferior vena cava diameter predict fluid responsiveness: a systematic review and meta-analysis. Shock. 2017;47(5):550–9. https://doi.org/10.1097/SHK.0000000000000801.
Cameli M, Bigio E, Lisi M, Righini FM, Galderisi M, Franchi F, Scolletta S, Mondillo S. Relationship between pulse pressure variation and echocardiographic indices of left ventricular filling pressure in critically ill patients. Clin Physiol Funct Imaging. 2015;35(5):344–50. https://doi.org/10.1111/cpf.12168.
Cinotti R, Roquilly A, Mahé PJ, Feuillet F, Yehia A, Belliard G, Lejus C, Blanloeil Y, Teboul JL, Asehnoune K, ATLANRÉA Group. Pulse pressure variations to guide fluid therapy in donors: a multicentric echocardiographic observational study. J Crit Care. 2014;29(4):489–94. https://doi.org/10.1016/j.jcrc.2014.03.027.
Mahjoub Y, Pila C, Friggeri A, Zogheib E, Lobjoie E, Tinturier F, Galy C, Slama M, Dupont H. Assessing fluid responsiveness in critically ill patients: false-positive pulse pressure variation is detected by Doppler echocardiographic evaluation of the right ventricle. Crit Care Med. 2009;37(9):2570–5. https://doi.org/10.1097/CCM.0b013e3181a380a3.
Huang H, Shen Q, Liu Y, Xu H, Fang Y. Value of variation index of inferior vena cava diameter in predicting fluid responsiveness in patients with cirulatory shock receiving mechanical ventilation: a systematic review and meta-analysis. Crit Care. 2018;22(1):204. https://doi.org/10.1186/s13054-018-2063-4.
Preau S, Bortolotti P, Colling D, Dewavrin F, Colas V, Voisin B, Onimus T, Drumez E, Durocher A, Redheuil A, Saulnier F. Diagnostic accuracy of the inferior vena cava collapsibility to predict fluid responsiveness in spontaneously breathing patients with Sepsis and acute circulatory failure. Crit Care Med. 2017;45(3):e290–7. https://doi.org/10.1097/CCM.0000000000002090.
Vieillard-Baron A, Chergui K, Rabiller A, Peyrouset O, Page B, Beauchet A, Jardin F. Superior vena caval collapsibility as a gauge of volume status in ventilated septic patients. Intensive Care Med. 2004;30(9):1734–9. https://doi.org/10.1007/s00134-004-2361-y.
de Oliveira OH, Freitas FG, Ladeira RT, Fischer CH, Bafi AT, Azevedo LC, Machado FR. Comparison between respiratory changes in the inferior vena cava diameter and pulse pressure variation to predict fluid responsiveness in postoperative patients. J Crit Care. 2016;34:46–9. https://doi.org/10.1016/j.jcrc.2016.03.017.
Sobczyk D, Nycz K, Andruszkiewicz P, Wierzbicki K, Stapor M. Ultrasonographic caval indices do not significantly contribute to predicting fluid responsiveness immediately after coronary artery bypass grafting when compared to passive leg raising. Cardiovasc Ultrasound. 2016;14(1):23. https://doi.org/10.1186/s12947-016-0065-4.
Sobczyk D, Nycz K, Andruszkiewicz P. Bedside ultrasonographic measurement of the inferior vena cava fails to predict fluid responsiveness in the first 6 hours after cardiac surgery: a prospective case series observational study. J Cardiothorac Vasc Anesth. 2015;29(3):663–9. https://doi.org/10.1053/j.jvca.2014.08.015.
Duwat A, Zogheib E, Guinot P, Levy F, Trojette F, Diouf M, Slama M, Dupont H. The gray zone of the qualitative assessment of respiratory changes in inferior vena cava diameter in ICU patients. Crit Care. 2014;18(1):R14. https://doi.org/10.1186/cc13693.
(DGAI) DGfAuIeV. S3-Leitlinie Intravasale Volumentherapie beim Erwachsenen. Access. 2014;09(07):2018.
Vieillard-Baron A, Evrard B, Repessé X, Maizel J, Jacob C, Goudelin M, Charron C, Prat G, Slama M, Geri G, Vignon P. Limited value of end-expiratory inferior vena cava diameter to predict fluid responsiveness impact of intra-abdominal pressure. Intensive Care Med. 2018;44(2):197–203. https://doi.org/10.1007/s00134-018-5067-2.
Millington SJ. Ultrasound assessment of the inferior vena cava for fluid responsiveness: easy, fun, but unlikely to be helpful. Can J Anaesth. 2019;66(6):633–8. https://doi.org/10.1007/s12630-019-01357-0.
Haddad F, Couture P, Tousignant C, Denault AY. The right ventricle in cardiac surgery, a perioperative perspective: II. Pathophysiology, clinical importance, and management. Anesth Analg. 2009;108(2):422–33. https://doi.org/10.1213/ane.0b013e31818d8b92.
Hoeper MM, Granton J. Intensive care unit management of patients with severe pulmonary hypertension and right heart failure. Am J Respir Crit Care Med. 2011;184(10):1114–24. https://doi.org/10.1164/rccm.201104-0662CI.
Bootsma IT, de Lange F, Koopsmans M, Haenen J, Boonstra PW, Symersky T, Boerma EC. Right ventricular function after cardiac surgery is a strong independent predictor for Long-term mortality. J Cardiothorac Vasc Anesth. 2017;31(5):1656–62. https://doi.org/10.1053/j.jvca.2017.02.008.
Vlahakes GJ, Turley K, Hoffman JI. The pathophysiology of failure in acute right ventricular hypertension: hemodynamic and biochemical correlations. Circulation. 1981;63(1):87–95.
Carl M, Alms A, Braun J, Dongas A, Erb J, Goetz A, Goepfert M, Gogarten W, Grosse J, Heller AR, Heringlake M, Kastrup M, Kroener A, Loer SA, Marggraf G, Markewitz A, Reuter D, Schmitt DV, Schirmer U, Wiesenack C, Zwissler B, Spies C. S3 guidelines for intensive care in cardiac surgery patients: hemodynamic monitoring and cardiocirculary system. Ger Med Sci. 2010;8. https://doi.org/10.3205/000101.
Kukucka M, Stepanenko A, Potapov E, Krabatsch T, Redlin M, Mladenow A, Kuppe H, Hetzer R, Habazettl H. Right-to-left ventricular end-diastolic diameter ratio and prediction of right ventricular failure with continuous-flow left ventricular assist devices. J Heart Lung Transplant. 2011;30(1):64–9. https://doi.org/10.1016/j.healun.2010.09.006.
Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1–39.e14. https://doi.org/10.1016/j.echo.2014.10.003.
Gudmundsson P, Rydberg E, Winter R, Willenheimer R. Visually estimated left ventricular ejection fraction by echocardiography is closely correlated with formal quantitative methods. Int J Cardiol. 2005;101(2):209–12. https://doi.org/10.1016/j.ijcard.2004.03.027.
Prada G, Fritz VA, Restrepo-Holguín M, Guru PK, Díaz-Gómez JL. Focused cardiac ultrasonography for left ventricular systolic function. N Engl J Med. 2019;381(21):e36. https://doi.org/10.1056/NEJMvcm1802841.
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, Authors/Task Force M, Document R. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the heart failure association (HFA) of the ESC. Eur J Heart Fail. 2016;18(8):891–975. https://doi.org/10.1002/ejhf.592.
Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T, Flachskampf FA, Gillebert TC, Klein AL, Lancellotti P, Marino P, Oh JK, Popescu BA, Waggoner AD. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016;29(4):277–314. https://doi.org/10.1016/j.echo.2016.01.011.
Pieske B, Tschöpe C, de Boer RA, Fraser AG, Anker SD, Donal E, Edelmann F, Fu M, Guazzi M, CSP L, Lancelotti P, Melenovsky V, Morris DA, Nagel E, Pieske-Kraigher E, Ponikowski P, Solomon SD, Vasan RS, Rutten FH, Voors AA, Ruschitzka F, Paulus WJ, Seferovic P, Filippatos G. How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the heart failure association (HFA) of the European Society of Cardiology (ESC). Eur Heart J. 2019;40(40):3297–317. https://doi.org/10.1093/eurheartj/ehz641.
Leischik R, Dworrak B, Sanchis-Gomar F, Lucia A, Buck T, Erbel R. Echocardiographic assessment of myocardial ischemia. Ann Transl Med. 2016;4(13):259. https://doi.org/10.21037/atm.2016.07.06.
Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, Iung B, Otto CM, Pellikka PA, Quiñones M. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr. 2009;22(1):1–23.; quiz 101-102. https://doi.org/10.1016/j.echo.2008.11.029.
Lancellotti P, Tribouilloy C, Hagendorff A, Moura L, Popescu BA, Agricola E, Monin J-L, Pierard LA, Badano L, Zamorano JL. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 1: aortic and pulmonary regurgitation (native valve disease). Eur J Echocardiogr. 2010;11(3):223–44. https://doi.org/10.1093/ejechocard/jeq030.
Lancellotti P, Moura L, Pierard LA, Agricola E, Popescu BA, Tribouilloy C, Hagendorff A, Monin J-L, Badano L, Zamorano JL. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr. 2010;11(4):307–32. https://doi.org/10.1093/ejechocard/jeq031.
Wetterslev M, Moller-Sorensen H, Johansen RR, Perner A. Systematic review of cardiac output measurements by echocardiography vs. thermodilution: the techniques are not interchangeable. Intensive Care Med. 2016;42(8):1223–33. https://doi.org/10.1007/s00134-016-4258-y.
Blanco P, Aguiar FM, Blaivas M. Rapid ultrasound in shock (RUSH) velocity-time integral: a proposal to expand the RUSH protocol. J Ultrasound Med. 2015;34(9):1691–700. https://doi.org/10.7863/ultra.15.14.08059.
Graeser K, Zemtsovski M, Kofoed KF, Winther-Jensen M, Nilsson JC, Kjaergaard J, Moller-Sorensen H. Comparing methods for cardiac output: intraoperatively Doppler-derived cardiac output measured with 3-dimensional echocardiography is not interchangeable with cardiac output by pulmonary catheter Thermodilution. Anesth Analg. 2018;127(2):399–407.
Jozwiak M, Monnet X, Teboul JL. Less or more hemodynamic monitoring in critically ill patients. Curr Opin Crit Care. 2018;24(4):309–15. https://doi.org/10.1097/MCC.0000000000000516.
Heringlake M, Sander M, Treskatsch S, Brandt S, Schmidt C (2018) Hemodynamic target variables in the intensive care unit. Anaesthesist. Epub ahead of print. https://doi.org/10.1007/s00101-018-0489-3.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Trauzeddel, R.F., Berger, C., Treskatsch, S. (2021). Hemodynamic Focused Echocardiography. In: Kirov, M.Y., Kuzkov, V.V., Saugel, B. (eds) Advanced Hemodynamic Monitoring: Basics and New Horizons. Springer, Cham. https://doi.org/10.1007/978-3-030-71752-0_10
Download citation
DOI: https://doi.org/10.1007/978-3-030-71752-0_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-71751-3
Online ISBN: 978-3-030-71752-0
eBook Packages: MedicineMedicine (R0)